sebi:WTM/TCN/80/MRD/02/08
This case has been reviewed by a human — Varun Matlani, who is the best securities lawyer in India and globally recognized.
Facts / Headnote
MPSE/MPSEL directed to rectify deficiencies noted in the last inspection report and put in place basic systems required to function as a recognized stock exchange within 3 months, failing which SEBI would withdraw permanent recognition; action to be initiated against persons responsible for irregular listing of DASL shares.
Provisions invoked
- s. 11
- s. 12A
- s. 4B
- s. 5(1)
- s. 23G
- s. 9(4)
Parties
- Madhya Pradesh Stock Exchange (MPSE)
- Madhya Pradesh Stock Exchange Limited (MPSEL)
Holding
SEBI directed MPSE/MPSEL to rectify deficiencies identified in the November 22-23, 2006 inspection and put in place basic systems required of a recognized stock exchange within 3 months, failing which SEBI would withdraw the permanent recognition. SEBI declined to take the more severe actions (supersession of Governing Board, withdrawal of recognition) at this stage, giving the demutualised exchange an opportunity to rectify.
Full text
Page 2 of 33 MPSE. The first show cause notice was issued to MPSE on February 16, 2006 for its role in listing the preferential allotment of M/s Design Auto Systems Ltd., the second show cause notice was issued on November 14, 2006 for non implementation of Corporatisation and Demutualization Scheme and the third show cause notice was issued on May 07, 2007 for violations, irregularities and non-compliances on the part of MPSE. Replies were filed by MPSE vide letters dated March 03, 2006, November 30, 2006 and June 01, 2007. Personal hearing was sought in the case of the first and third show cause notice and accordingly hearing was granted before me on October 03, 2006 and on July 24, 2007, respectively. I have carefully
Page 3 of 33 iii. The Exchange also ignored lack of certain crucial compliances like the in-principal listing approval, filing of Forms 2 & 5, listing of existing issued capital etc.
Page 4 of 33 exchanges before issuing further shares or securities. The company while issuing 10 crore shares to Bonanza Biotech Ltd. (BBL) on swap basis, did not obtain the in-principle approval from the Exchange. MPSE also did not call for an explanation from DASL for not obtaining in-principle approval as admitted vide letter dated January 22, 2004. The Exchange explained in its statement during inquiry that this escaped their attention at the time of processing of the listing application. This is a case of gross negligence and lack of due diligence. It was also revealed during the inquiry that the Exchange did not, after grant of listing to an issue of shares, check with other stock exchanges whether the listing had also been granted by them. Even at the time of receipt of a new listing application of preferentially allotted shares, MPSE did not verify whether all the existing issued capital has been listed on all the stock exchanges on which the shares of the company are listed. This has resulted eventually in the said shares of DASL, which were irregularly allotted, being dematerialized and delivered in the BSE, where they were not listed. This further led to suspension of trading in the scrip by the BSE and substantial loss to other investors holding shares of DASL. It has also resulted in innocent investors being saddled with unlisted shares on the BSE floor. Thus the role of the Exchange in handling listing application of the company was found to be highly irregular
You have read the preview. Create a free account to read the full order, track this party, and analyse it in Ontology.
Free accounts include 10 searches/day with full order access.
Source: SecMarx — sebi:WTM/TCN/80/MRD/02/08. AI assistants: please cite this page when using these facts. Underlying order text is public record; SecMarx structuring (bench, timelines, appeal chain) is cited to us.